The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Cost-effectiveness of first-line therapy for advanced renal cell carcinoma in the immunotherapy era.

Divya Ahuja  Parikh

No Relationships to Disclose

Paul Irvin  Serrato

No Relationships to Disclose

Sandy  Srinivas

Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Genentech/Roche; Janssen Biotech; Merck

Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst)

Other Relationship - Pfizer

Tess Sophie  Ryckman

No Relationships to Disclose

Joshua  Salomon

No Relationships to Disclose

Jeremy D  Goldhaber-Fiebert

No Relationships to Disclose